Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 1/20 | 0.52 |
| ▸ | TERT | O14746 | 5/20 | 0.52 |
| ▸ | TOP1 | P11387 | 4/20 | 0.45 |
| ▸ | CYCS | P99999 | 4/20 | 0.44 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.44 |
| ▸ | ELANE | P08246 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8181762 | 0.90 | ENPP2 (0.66) | ENPP2TERTTOP1CYCSABCG2 | |
| Magnesium SCHEMBL30566378 | 0.89 | TOP1 (0.53) | ENPP2TERTTOP1CYCSABCG2 | |
| SCHEMBL30566373 | 0.89 | TOP1 (0.53) | ENPP2TERTTOP1CYCSABCG2 | |
| SCHEMBL30566372 | 0.89 | TOP1 (0.53) | ENPP2TERTTOP1CYCSABCG2 | |
| SCHEMBL7262340 | 0.85 | TOP1 (0.53) | ENPP2TERTTOP1CYCSABCG2 | |
| SCHEMBL31019566 | 0.84 | TOP1 (0.52) | ENPP2TERTTOP1CYCSABCG2 | |
| Acetic Acid SCHEMBL7939597 | 0.81 | ENPP2 (0.64) | ENPP2TERTTOP1CYCSABCG2 | |
| Zinc Ion SCHEMBL11569891 | 0.81 | ENPP2 (0.70) | ENPP2TERTTOP1CYCSABCG2 | |
| Zinc Ion SCHEMBL31042928 | 0.81 | ENPP2 (0.70) | ENPP2TERTTOP1CYCSABCG2 | |
| SCHEMBL23706379 | 0.79 | ENPP2 (0.70) | ENPP2TERTTOP1CYCSABCG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0891977-B1 | 5-(4-Hydroxyphenyl)-porphyrin derivatives as photosensitisers | DLR EV (DE) | 2003-01-29 | — | — | EP | disclosed |